Please login to the form below

Webinar: What next for biosimilars?

Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST

Biosimilar medicines appear to present a significant opportunity to introduce cutting-edge therapies to the treatment landscape for many diseases, while also addressing the cost-effectiveness demands now being made on global healthcare systems. However, these drugs aren’t cheap or easy to manufacture and come with considerable marketing challenges.
Join market research consultants Laurent Chanroux and Richard Head for this complimentary webinar in which they will explore and compare biosimilars in RA and diabetes.

http://www.researchpartnership.com/news/2016/06/webinar-what-next-for-biosimilars/

6th July 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Add my company

Edit my company

Latest content on this profile

Infographic: Living with: The journey from the patient’s perspective: View our re-vamped interactive infographic to unlock key insights from various Living With reports
Research Partnership
Case study: How we iteratively tested and refined payer value messages: Find out how we helped our client to enrich their understanding of the value message trade-off choices and preferences made by payers
Research Partnership
Video: Strategic engagement case study: Supporting the launch of a global vaccine with a programme of market research and strategic insights
Research Partnership
Webcast: The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions: Watch to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes.
Research Partnership
Research Partnership appoints new CEO: Research Partnership has appointed Gareth Phillips to take over as CEO
Research Partnership
Infographic: Therapy Watch Hyperlipidaemia: Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study.
Research Partnership